69
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Developmental Plasticity Is Bound by Pluripotency and the Fgf and Wnt Signaling Pathways

      brief-report
      1 , 2 , 3 , 1 , 2 , 1 , 2 ,
      Cell Reports
      Cell Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Plasticity is a well-known feature of mammalian development, and yet very little is known about its underlying mechanism. Here, we establish a model system to examine the extent and limitations of developmental plasticity in living mouse embryos. We show that halved embryos follow the same strict clock of developmental transitions as intact embryos, but their potential is not equal. We have determined that unless a minimum of four pluripotent cells is established before implantation, development will arrest. This failure can be rescued by modulating Fgf and Wnt signaling to enhance pluripotent cell number, allowing the generation of monozygotic twins, which is an otherwise rare phenomenon. Knowledge of the minimum pluripotent-cell number required for development to birth, as well as the different potentials of blastomeres, allowed us to establish a protocol for splitting an embryo into one part that develops to adulthood and another that provides embryonic stem cells for that individual.

          Abstract

          Graphical Abstract

          Highlights

          ► Half embryos follow the same clock as intact embryos, but their potential is not equal ► To support development, four pluripotent cells must be generated before implantation ► Fgf/Wnt signal modulation enhances pluripotency to rescue half-embryo development ► ESCs and a viable mouse can be derived from a single embryo with high efficiency

          Abstract

          It is a well-known feature of early mouse development that healthy mice can form from embryos split into two parts. How the mouse achieves this remarkable feat is unknown; thus, Morris, Guo, and Zernicka-Goetz examined this phenomenon by filming halved embryos as they developed. They found that some half embryos do not make enough pluripotent cells to support development, but this deficiency can be rescued by modulating Fgf and Wnt signaling. Using this rescue, the authors were able to derive embryonic stem cells without compromising embryo viability.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway.

          It has been thought that early inner cell mass (ICM) is a homogeneous population and that cell position in the ICM leads to the formation of two lineages, epiblast (EPI) and primitive endoderm (PE), by E4.5. Here, however, we show that the ICM at E3.5 is already heterogeneous. The EPI- and PE-specific transcription factors, Nanog and Gata6, were expressed in the ICM in a random "salt and pepper" pattern, as early as E3.5, in a mutually exclusive manner. Lineage tracing showed predominant lineage restriction of single ICM cells at E3.5 to either lineage. In embryos lacking Grb2 where no PE forms, Gata6 expression was lost and all ICM cells were Nanog positive. We propose a model in which the ICM develops as a mosaic of EPI and PE progenitors at E3.5, dependent on Grb2-Ras-MAP kinase signaling, followed by later segregation of the progenitors into the appropriate cell layers.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Distinct sequential cell behaviours direct primitive endoderm formation in the mouse blastocyst.

            The first two lineages to differentiate from a pluripotent cell population during mammalian development are the extraembryonic trophectoderm (TE) and the primitive endoderm (PrE). Whereas the mechanisms of TE specification have been extensively studied, segregation of PrE and the pluripotent epiblast (EPI) has received comparatively little attention. A current model of PrE specification suggests PrE precursors exhibit an apparently random distribution within the inner cell mass of the early blastocyst and then segregate to their final position lining the cavity by the late blastocyst. We have identified platelet-derived growth factor receptor alpha (Pdgfralpha) as an early-expressed protein that is also a marker of the later PrE lineage. By combining live imaging of embryos expressing a histone H2B-GFP fusion protein reporter under the control of Pdgfra regulatory elements with the analysis of lineage-specific markers, we investigated the events leading to PrE and EPI lineage segregation in the mouse, and correlated our findings using an embryo staging system based on total cell number. Before blastocyst formation, lineage-specific factors are expressed in an overlapping manner. Subsequently, a gradual progression towards a mutually exclusive expression of PrE- and EPI-specific markers occurs. Finally, cell sorting is achieved by a variety of cell behaviours and by selective apoptosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Histone arginine methylation regulates pluripotency in the early mouse embryo.

              It has been generally accepted that the mammalian embryo starts its development with all cells identical, and only when inside and outside cells form do differences between cells first emerge. However, recent findings show that cells in the mouse embryo can differ in their developmental fate and potency as early as the four-cell stage. These differences depend on the orientation and order of the cleavage divisions that generated them. Because epigenetic marks are suggested to be involved in sustaining pluripotency, we considered that such developmental properties might be achieved through epigenetic mechanisms. Here we show that modification of histone H3, through the methylation of specific arginine residues, is correlated with cell fate and potency. Levels of H3 methylation at specific arginine residues are maximal in four-cell blastomeres that will contribute to the inner cell mass (ICM) and polar trophectoderm and undertake full development when combined together in chimaeras. Arginine methylation of H3 is minimal in cells whose progeny contributes more to the mural trophectoderm and that show compromised development when combined in chimaeras. This suggests that higher levels of H3 arginine methylation predispose blastomeres to contribute to the pluripotent cells of the ICM. We confirm this prediction by overexpressing the H3-specific arginine methyltransferase CARM1 in individual blastomeres and show that this directs their progeny to the ICM and results in a dramatic upregulation of Nanog and Sox2. Thus, our results identify specific histone modifications as the earliest known epigenetic marker contributing to development of ICM and show that manipulation of epigenetic information influences cell fate determination.
                Bookmark

                Author and article information

                Journal
                Cell Rep
                Cell Rep
                Cell Reports
                Cell Press
                2211-1247
                25 October 2012
                25 October 2012
                : 2
                : 4
                : 756-765
                Affiliations
                [1 ]Wellcome Trust/Cancer Research Gurdon Institute, Cambridge CB2 1QN, UK
                [2 ]Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge CB2 3DY, UK
                Author notes
                []Corresponding author mzg@ 123456mole.bio.cam.ac.uk
                [3]

                Present address: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, and Boston Children’s Hospital, Boston, MA 02115, USA

                Article
                CELREP153
                10.1016/j.celrep.2012.08.029
                3607220
                23041313
                2e30ec0c-c3fe-46b6-b605-79a9ebb5186a
                © 2012 The Authors
                History
                : 9 July 2012
                : 15 August 2012
                : 27 August 2012
                Categories
                Report

                Cell biology
                Cell biology

                Comments

                Comment on this article